- Sponsored by Vera Therapeutics - Emerging Therapies for IgA Nephropathy: Targeting BAFF and APRIL with Atacicept
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
| 12:15 - 12:30 | Overview of the Unmet Need in IgA Nephropathy and Disease Markers |
Muh Geot Wong |
Muh Geot Wong |
Room 2 ( 701B ) |
| 12:30 - 12:45 | Emerging Therapies Targets in IgAN and the Role of Cytokines BAFF and APRIL |
Sydney Tang |
Muh Geot Wong |
Room 2 ( 701B ) |
| 12:45 - 13:00 | Targeting BAFF and APRIL with Atacicept |
Jonathan Barratt |
Muh Geot Wong |
Room 2 ( 701B ) |
| 13:00 - 13:15 | Q & A |
Muh Geot Wong |
Room 2 ( 701B ) |
- Sponsored by Novartis
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
| 12:15 - 12:25 | Opening |
Shang-Jyh Hwang |
Room 3 ( 701C ) | |
| 12:25 - 12:40 | Australia's Perspective |
Germaine Wong |
Shang-Jyh Hwang |
Room 3 ( 701C ) |
| 12:40 - 12:55 | Taiwan's Perspective |
Yi-Wen Chiu |
Shang-Jyh Hwang |
Room 3 ( 701C ) |
| 12:55 - 13:10 | Panel Discussion |
Shang-Jyh Hwang |
Room 3 ( 701C ) | |
| 13:10 - 13:15 | Closing |
Shang-Jyh Hwang |
Room 3 ( 701C ) |
- Sponsored by DKSH - CKD-MBD in Focus: How Early SHPT Treatment Can Change Long-Term Outcomes
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
| 12:15 - 12:20 | Opening Remark |
Kuo-Cheng Lu |
Room 4 ( 701EF ) | |
| 12:20 - 12:45 | The Importance of Early Calcimimetic Use in SHPT: A Personalized Treatment Perspective |
Chia-Chao Wu |
Kuo-Cheng Lu |
Room 4 ( 701EF ) |
| 12:45 - 13:10 | Early Engagement in SHPT: Clinical Rationale and Japanese Insights |
Hirotaka Komaba |
Kuo-Cheng Lu |
Room 4 ( 701EF ) |
| 13:10 - 13:15 | Q & A |
Kuo-Cheng Lu |
Room 4 ( 701EF ) |
- Sponsored by Tai Tien Pharmaceuticals CO., LTD.
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
| 12:15 - 13:15 | Treatment of Renal Anemia during Dialysis |
Nangaku Masaomi |
Der-Cherng Tarng |
Room 5 ( 701G ) |
- Sponsored by AstraZeneca Taiwan Limited
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
| 12:30 - 13:30 | Emerging Treatments and Barriers for CKD Managements - Road to A Better Kidney Health |
Hiddo Lambers Heerspink |
Mai-Szu Wu |
Room 1 ( 701A ) |
- Sponsored by Hua Chiang Medical
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
| 12:30 - 13:10 | Expanded HD vs HDF Treatment -Evolution of The Latest Technologies and Future Prospects |
Akihiro C. Yamashita |
Kuo-Cheng Lu |
Room 2 ( 701B ) |
| 13:10 - 13:25 | A Randomized Crossover Trial of Super High-Flux Elisio HX Dialyzer Versus High-Flux Dialyzers on Biomarkers and Quality of Life Outcomes in Maintenance Hemodialysis Patients |
Ko-Lin Kuo |
Kuo-Cheng Lu |
Room 2 ( 701B ) |
| 13:25 - 13:30 | Q & A |
Kuo-Cheng Lu |
Room 2 ( 701B ) |
- Sponsored by Novartis
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
| 12:30 - 12:35 | Opening |
Kuan-Yu Hung |
Room 3 ( 701C ) | |
| 12:35 - 13:15 | Unlocking the Future of IgA Nephropathy: Innovative Development for Better Patient Outcomes |
Chee-Kay Cheung |
Kuan-Yu Hung |
Room 3 ( 701C ) |
| 13:15 - 13:25 | Panel Discussion |
Kuan-Yu Hung |
Room 3 ( 701C ) | |
| 13:25 - 13:30 | Closing |
Kuan-Yu Hung |
Room 3 ( 701C ) |
- Sponsored by Otsuka
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
| 12:30 - 13:30 | Exploring the Role of B Cells in IgA Nephropathy: Pathogenesis to Progression |
Muh Geot Wong |
Wen-Chih Chiang |
Room 4 ( 701EF ) |
- Sponsored by Bayer - The Finerenone Era: Enhancing CONFIDENCE and Transforming Management in CKD and T2D
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
| 12:30 - 12:45 | Opening & Session 1 - Finerenone's Role in Preventing Cardiorenal Risk in Patients with CKD and T2D |
Ming-Ju Wu |
Masaomi Nangaku Ming-Ju Wu |
Room 5 ( 701G ) |
| 12:45 - 13:00 | Session 2 - Unleashing Potential: Overcoming Barriers to Finerenone Adoption in Clinical Practice |
Tushar Dighe |
Masaomi Nangaku Ming-Ju Wu |
Room 5 ( 701G ) |
| 13:00 - 13:15 | Session 3 - One plus One just more than Two – From Evidence to CONFIDENCE: Empowering Asian Patients through decoding CONFIDENCE Tria |
Johannes Mann |
Masaomi Nangaku Ming-Ju Wu |
Room 5 ( 701G ) |
| 13:15 - 13:25 | Panel Discussion |
Masaomi Nangaku Ming-Ju Wu |
Room 5 ( 701G ) | |
| 13:25 - 13:30 | Closing |
Masaomi Nangaku Ming-Ju Wu |
Room 5 ( 701G ) |
- Sponsored by Vantive - HDx Spotlight-- Redefine HD: Bridging the Gap Between Innovation and Daily Practice
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
| 12:30 - 12:35 | Opening |
Tai-Shuan Lai |
Room 6 ( 702 ) | |
| 12:35 - 13:15 | Protecting What Remains: New HDx RCT Insights on Preserving Residual Kidney Function & Improving Outcomes |
Jang-Hee Cho |
Tai-Shuan Lai |
Room 6 ( 702 ) |
| 13:15 - 13:25 | Panel Discussion |
Tai-Shuan Lai |
Room 6 ( 702 ) | |
| 13:25 - 13:30 | Closing Remarks |
Tai-Shuan Lai |
Room 6 ( 702 ) |
- Sponsored by Novo Nordisk
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
| 12:30 - 13:30 | Moving from Evidence to Practice of Breakthrough Therapy for Diabetic Kidney Disease |
Wei-Hung Lin |
Wei-Cheng Tseng |
Room 7 ( 703 ) |
- Sponsored by Vantive - Enhancing Home Dialysis Through Digital Connectivity
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
| 12:30 - 12:35 | Opening |
Chih-Yu Yang |
Room 1 ( 701A ) | |
| 12:35 - 12:55 | Optimizing Outcomes in Home Based PD with Remote Patient Management |
Chia-Chun Lee |
Chih-Yu Yang |
Room 1 ( 701A ) |
| 12:55 - 13:15 | Expanding the Reach of Remote Patient Management: Empowering PD Patients |
Gangjee Ko |
Chih-Yu Yang |
Room 1 ( 701A ) |
| 13:15 - 13:25 | Q & A |
Chih-Yu Yang |
Room 1 ( 701A ) | |
| 13:25 - 13:30 | Closing |
Chih-Yu Yang |
Room 1 ( 701A ) |
- Sponsored by Everest Medicines
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
| 12:30 - 13:30 | Why Target the Gut to Treat the Kidneys? A New Treatment Paradigm for IgA Nephropathy |
Jonathan Barratt |
Min-Yu Chang Yen-Ling Chiu |
Room 2 ( 701B ) |
- Sponsored by Boehringer Ingelheim
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
| 12:30 - 13:30 | Pushing the Boundaries: Long-Term Renal Preservation with Empagliflozin Across the eGFR Spectrum |
Bobby Chacko |
Mai-Szu Wu |
Room 3 ( 701C ) |
- Sponsored by FME - Person-Centered Approach to Dialysis Care in the Sustainability Era
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
| 12:30 - 13:00 | Where Do Person-Centered Home Therapies Fit Into the Kidney Life Plan? |
David Law |
Chiu-Ching Huang |
Room 4 ( 701EF ) |
| 13:00 - 13:30 | HDF for Better Outcomes and Sustainability: From Global Evidence to Real-World Practice in Korea |
Ju-Young Moon |
Chiu-Ching Huang |
Room 4 ( 701EF ) |
- Sponsored by Fresenius Kabi Taiwan Ltd. - How Can Keto-analogues Help in The New Era of CKD Therapy
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
| 12:30 - 12:35 | Opening |
Chih-Wei Yang |
Room 5 ( 701G ) | |
| 12:35 - 13:15 | How Can Keto-analogues Help in the New Era of CKD Therapy |
Kamyar Kalantar-Zadeh |
Chih-Wei Yang |
Room 5 ( 701G ) |
| 13:15 - 13:30 | Q & A |
Chih-Wei Yang |
Room 5 ( 701G ) |
- Sponsored by Novartis - Entresto in Nephrology: Expanding the Therapeutic Horizon
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
| 12:30 - 12:35 | Opening |
Tai-Shuan Lai |
Room 6 ( 702 ) | |
| 12:35 - 13:15 | ARNI Beyond the Heart: Unveiling Renal Protection Across the CKD Spectrum |
Hsuan-Jen Lin |
Tai-Shuan Lai |
Room 6 ( 702 ) |
| 13:15 - 13:25 | Panel Discussion |
Tai-Shuan Lai |
Room 6 ( 702 ) | |
| 13:25 - 13:30 | Closing |
Tai-Shuan Lai |
Room 6 ( 702 ) |
- Sponsored by GSK
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
| 12:30 - 13:30 | Bridging Risk and Prevention: Shingles Management Insights for Nephrologists |
I-Wen Wu |
Yi-Wen Chiu |
Room 7 ( 703 ) |
- Sponsored by Bayer - Unlocking the Future of CKD Treatment: Insights from the CONFIDENCE Study and Beyond
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
|
12/5 12:15 - 12:18 |
Welcome and Introductions |
Chih-Ching Lin |
Chih-Ching Lin |
Exhibitor Spotlight |
|
12/5 12:18 - 12:33 |
Navigating the Future of CKD Management: Unlocking Mechanisms and Potential of Finerenone - Mechanism of Action, Clinical Benefits with Insights from the CONFIDENCE Study, and Practical Considerations in Combination Treatments for Patients with CKD and T2D |
Johannes Mann |
Chih-Ching Lin |
Exhibitor Spotlight |
|
12/5 12:33 - 12:38 |
Navigating the Future of CKD Management: Unlocking Mechanisms and Potential of Finerenone - Integrating Cardiometabolic and Renal Protection: Treatment Strategies for A 55-year-old Woman with T2D and Early CKD |
Chih-Ching Lin |
Chih-Ching Lin |
Exhibitor Spotlight |
|
12/5 12:38 - 12:53 |
Navigating the Future of CKD Management: Unlocking Mechanisms and Potential of Finerenone - Panel Discussion and Q & A |
Chih-Ching Lin |
Exhibitor Spotlight | |
|
12/5 12:53 - 13:03 |
Tailoring Treatment: Real-world Insights and Practical Applications of Finerenone in Patients with CKD and T2D - Efficacy and Safety of Simultaneous Finerenone and SGLT-2 Inhibitor Initiation: Insights from the CONFIDENCE Asian Subanalysis |
Eun Hui Bae |
Chih-Ching Lin |
Exhibitor Spotlight |
|
12/5 13:03 - 13:08 |
Tailoring Treatment: Real-world Insights and Practical Applications of Finerenone in Patients with CKD and T2D - Clinical Considerations in the Management of CKD and T2D |
Johannes Mann |
Chih-Ching Lin |
Exhibitor Spotlight |
|
12/5 13:08 - 13:13 |
Tailoring Treatment: Real-world Insights and Practical Applications of Finerenone in Patients with CKD and T2D - Panel Discussion and Q & A |
Chih-Ching Lin |
Exhibitor Spotlight | |
|
12/5 13:13 - 13:15 |
Closing Remarks |
Chih-Ching Lin |
Exhibitor Spotlight |
- Sponsored by Boehringer Ingelheim - When the Heart and Kidneys Collide: A Clinical Crosstalk
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
|
12/6 12:35 - 12:55 |
CV Case: Initiation of Empagliflozin in Acute MI Patients with Advanced CKD |
Yi-Hsin Chan |
Yi-Wen Chiu |
Exhibitor Spotlight |
|
12/6 12:55 - 13:15 |
Renal Case: Initiation of Empagliflozin in Advanced CKD Patients |
Szu-Chun Hung |
Yi-Wen Chiu |
Exhibitor Spotlight |
|
12/6 13:15 - 13:30 |
Cardio-Renal Care Dialogues: (Q&A Panel & Closing) |
Yi-Hsin Chan Szu-Chun Hung |
Yi-Wen Chiu |
Exhibitor Spotlight |
- Sponsored by Novo Nordisk
| Time (UTC+8) | Topic | Speaker | Moderator | Room |
|---|---|---|---|---|
|
12/7 10:40 - 11:40 |
Knowing More About the New Pillar of CKM Treatment |
Chih-Chao Yang |
Shuei-Liong Lin |
Exhibitor Spotlight |